Viridian Therapeutics, Inc. (VRDN) shares outstanding

Shares outstanding · fiscal 2025
84.80M

Viridian Therapeutics, Inc. (VRDN) had 84.80M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 24.9% higher than the 67.89M of fiscal 2024. Figures as of 18 Nov 2026, 10:33 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
84.80M
Change on fiscal 2024
+24.9%
Highest on record
84.80Mfiscal 2025
Lowest on record
32.09Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Viridian Therapeutics, Inc. shares outstanding, in more detail

The market data feed counts 113.56M shares outstanding today.

Across the 4 fiscal years on record (2022–2025), the highest was 84.80M in fiscal 2025 and the lowest 32.09M in fiscal 2022.

History · 4 fiscal years

Shares outstanding by fiscal year

Viridian Therapeutics, Inc. shares outstanding, year by year

Viridian Therapeutics, Inc. (VRDN) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202584.80M 24.9% up
202467.89M 51.7% up
202344.76M 39.5% up
202232.09M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on VRDN

Viridian Therapeutics, Inc., figure by figure

Viridian Therapeutics, Inc. (VRDN) overview: price, valuation and scorecard

Viridian Therapeutics, Inc. shares outstanding: questions and answers

How many shares does Viridian Therapeutics, Inc. have?

Viridian Therapeutics, Inc. (VRDN) had 84.80M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 24.9% higher than the 67.89M of fiscal 2024. The market data feed counts 113.56M shares outstanding today.

What are the highest and lowest diluted share count figures on record for Viridian Therapeutics, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was 84.80M in fiscal 2025 and the lowest 32.09M in fiscal 2022.

How is Viridian Therapeutics, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Viridian Therapeutics, Inc. it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Viridian Therapeutics, Inc. (VRDN) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/VRDN/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.